Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001215884 | SCV001387652 | uncertain significance | Colorectal cancer, hereditary nonpolyposis, type 7 | 2022-10-30 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 945281). This variant has not been reported in the literature in individuals affected with MLH3-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.01%). This sequence change disrupts the translational stop signal of the MLH3 mRNA. It is expected to extend the length of the MLH3 protein by 18 additional amino acid residues. |
Ambry Genetics | RCV004033981 | SCV005037248 | uncertain significance | not specified | 2023-12-20 | criteria provided, single submitter | clinical testing | The c.4360T>C variant (also known as p.*1454Rext*18), located in coding exon 12 of the MLH3 gene, results from a T to C substitution at nucleotide position 4360, which is the last nucleotide of the MLH3 gene. The stop codon at position 1454 is replaced by arginine, resulting in an elongation of the protein by 18 amino acids. The evidence for this gene-disease relationship is limited; therefore, the clinical significance of this alteration is unclear. |